Who we are

Faison Associates is a network of highly experienced and capable regulatory medical writers, quality control experts, and business collaborators that has been developed and refined over decades of biopharmaceutical industry experience.

Our cross-functional team management expertise and project management experience will help you adhere strict development timelines while maintaining high quality standards. Let our team maximize the efficiency of your team.

Faison Associates offers a comprehensive range of medical writing and document development support services tailored to your specific needs.

Benefits

  • Turnkey and cohesive high-functioning teams that integrate quickly with your organization

  • Flexible writers, dedicated to address program changes and evolving needs

  • High-quality deliverables, produced efficiently

Outcomes

  • Reduce challenges during clinical development

  • Minimize development costs

  • Assure regulatory compliance

  • Accelerate time to market

  • Ruta began her career in the non-clinical setting, working as a laboratory technician conducting safety and toxicity tests in laboratory animals. At Schering Animal Health, she joined the regulatory submission team and advanced to managing dossier assembly for veterinary products. Transitioning to human drug development, Ruta worked as a clinical research associate before progressing through leadership roles, including submission team leader for Zetia in a joint venture with Merck.

    Ruta has leveraged her 20+ years of pharmaceutical experience into a successful career as a freelance medical writer, supporting a wide range of indications, documents, and submissions. She applies her deep expertise to help teams and clients efficiently achieve their goals.

  • Chris started his career as a clinical research associate, where he supported the submission and approval of the groundbreaking therapy, nitric oxide for inhalation. At Sanofi, Chris led oncology clinical study programs within Medical Affairs and subsequently in early development at ImClone. There he advanced to the role of Manager, Global Process Optimization, where he drove operational efficiencies across clinical programs.

    Chris has applied his 25 years of clinical and regulatory knowledge to medical writing consulting where he currently leads highly skilled teams. Most recently, his team has partnered with a gene therapy company, contributing to the development of innovative gene and cell therapies in oncology and hemoglobinopathies.